WebNeoadjuvant locoregional therapies are key to bridging hepatocellular carcinoma (HCC) patients to transplantation or resection. The primary endpoints of LEGACY were to evaluate local tumor control and duration of response in unresectable HCC following radiation treatment with Y90 glass microspheres as either a neoadjuvant or stand-alone therapy. Web1 jan. 2013 · Microsphere implantation is a hybrid of interstitial brachytherapy and radioactive liquid therapy which at the present time …
Pharmaceutics Free Full-Text Development of Arteannuin B …
WebMicrosphere technology is probably the only method that can be used for site-specific action, without causing significant side effects on normal cells. This review article … Web29 jun. 2013 · 90 Y-microsphere Therapy. 90 Y-microsphere therapy usually target the liver. AAPM 2012 Annual Meeting. 90 Y-microsphere therapy takes advantage of the unique. circulatory system in the liver – Portal vein (normal liver) & hepatic artery (tumor) Liver directed XRT are limited in scope – Radiation tolerance of normal hepatocytes … rdcworld j cole
Dosimetric Techniques in 90Y-Microsphere Therapy of Liver …
WebYttrium-90 microsphere therapy is being increasingly used for treatment of colorectal metastases to the liver. Patients who have failed systemic chemotherapy appear to … Web1 jan. 1987 · The spheres are insoluble in body fluids, non-toxic, and can concentrate in liver tumors of animals by direct injection into the hepatic artery. This gives a higher radiation … Webmicrosphere therapy To understand calculation of lung shunt fraction and estimation of absorbed dose for lung and liver To become familiar with radiation safety and regulations … rdcworld names